Fears that China’s outbreak of a new “coronavirus” shocked the stock market on Monday, sending the S&P 500 down 1.57% — and slicing 1.89% off the Nasdaq. What’s bad news for many companies, however, could be good news for one unprofitable medical specialist in particular: Novavax (NVAX).With its shares down 82% in 52 weeks, Novavax stock hasn’t had much to recommend itself to investors in recent months. However, rising panic over the effects of China’s coronavirus outbreak sent Novavax shares spiking sharply upwards — and that’s entirely understandable, even if it’s not entirely reasonable, as Ladenburg Thalmann analyst Michael Higgins …read more
Source:: Yahoo Finance
